84
Participants
Start Date
September 30, 2012
Primary Completion Date
July 10, 2017
Study Completion Date
July 20, 2017
Cabazitaxel
Dept of Medical Oncology, 251 General Air Force Hospital, Athens
"2nd Dept of Medical Oncology, General Hospital of Athens Hippokratio", Athens
"Oncology section, Dept of Clinical Therapeutics, General Hospital of Athens Alexandra", Athens
"Division of Oncology, 2nd Dept of Internal Medicine, Propaedeutic, University Hospital Attikon", Athens
2nd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens
3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens
3rd Dept of Medical Oncology, Hygeia Hospital, Athens
1st Dept of Medical Oncology, Metropolitan Hospital, Athens
2nd Dept of Medical Oncology, Metropolitan Hospital, Athens
"General Hospital of Patra Agios Andreas", Pátrai
Division of Oncology, Dept of Internal Medicine, University Hospital of Patras, Rio, Patras
Dept of Medical Oncology, Ioannina University Hospital, Ioannina
Dept of Medical Oncology, Papageorgiou General Hospital, Thessaloniki
Dept of Medical Oncology, Thermi Clinic S.A, Thessaloniki
Dept of Medical Oncology, University Hospital of Heraklion, Heraklio
"Oncology Dept., General Hospital of Chania Agios Georgios", Chania
2nd Dept of Medical Oncology, Agios Savvas Cancer Hospital, Athens
Collaborators (1)
Sanofi
INDUSTRY
Hellenic Cooperative Oncology Group
OTHER